Market Analysis - (2019) Volume 5, Issue 3
Shubhayan Sanatani,
Associate Professor, Head, Division of Cardiology, BC Children's Hospital, Canada., E-mail: ssanatani@cw.bc.ca
Conference Series LLC LTD Conferences invites all the participants from all over the world to attend “6th Annual Summit on Pediatric Cardiology” during October 30-31, 2020 in Vancouver, Canada which includes prompt Keynote sessions, Special talks, Symposiums, Workshops, Oral presentations, Poster presentations and Exhibitions. This congress will be organized around the theme of “Rising modernizations to save lives- Healthy Heart”.
The global market for interventional cardiology technologies makes an estimated $12.2 billion in 2014. According to a new study by Smithers - The Future of Coronary Artery Disease Medical Devices to 2021 - it will grow to $22.5 billion (€20.9 billion) by 2021, with a yearon- year increase of 9.1%. Demand for coronary artery disease medical devices will raise through 2021 as clinically viable and cost-effective solutions are developed. Currently North America is the largest geographic region by value with a market estimated to be worth $4.7 billion in 2014; this represents 38.8% of the global revenue. Smithers anticipates this market will experience an average annual growth of 7% over the forecast period.
The Asia-Pacific region, however, has grown spectacularly in its demand for interventional cardiology devices over the last decade. Today it represents the second greatest geographic region with a market value estimated at $3.6 billion in 2014 – a 29.8% global market share.
This auspicious outlook will continue with the Asia-Pacific seeing the highest growth rate, assumes by Smithers at an average of 13.3% per year, between 2014 and 2021. This will see it rise to an overall world market share of 38.7% at the beginning of the next decade, with North America at 33.8% pushed into second place.
